ATI RN
Nutrition and Fluid Balance Questions
Question 1 of 5
Which is not a possibility in the ECG of a pt with hypokalemia?
Correct Answer: D
Rationale: In the context of a patient with hypokalemia, the correct answer is D) Prolonged QT interval. Hypokalemia can lead to a variety of electrocardiogram (ECG) changes due to alterations in cardiac conduction and repolarization. A prolonged QT interval is a well-documented finding in hypokalemia and is associated with an increased risk of arrhythmias such as torsades de pointes. Option A) Prolonged PR interval is not typically seen in hypokalemia. Instead, hypokalemia is more commonly associated with a shortened QT interval due to the accelerated repolarization of cardiac myocytes. Option B) Prominent U waves are a classic ECG finding in hypokalemia. These U waves are seen following the T wave and are thought to represent repolarization abnormalities in the ventricles. Option C) T wave flattening is another ECG manifestation of hypokalemia. The T waves may appear less pronounced or flattened compared to a normal ECG tracing due to the altered repolarization of cardiac cells. Understanding the ECG changes associated with electrolyte imbalances like hypokalemia is crucial for healthcare providers, especially in settings where quick identification and intervention are necessary to prevent life-threatening cardiac complications. By recognizing these ECG patterns, healthcare professionals can promptly initiate appropriate treatment and prevent adverse outcomes in patients with electrolyte disturbances.
Question 2 of 5
Which drug is not well known to cause hyponatremia?
Correct Answer: D
Rationale: The correct answer is D) roxithromycin. Roxithromycin is an antibiotic that is not well known to cause hyponatremia. This is because hyponatremia, a condition characterized by low levels of sodium in the blood, is more commonly associated with certain types of medications and substances. Option A) sertraline is a selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression and anxiety. SSRIs like sertraline have been known to cause hyponatremia as a potential side effect due to the impact on the body's electrolyte balance. Option B) amitriptyline is a tricyclic antidepressant that has anticholinergic properties. Anticholinergic medications can lead to hyponatremia by affecting the body's ability to regulate sodium levels. Option C) ecstasy, or MDMA, is a recreational drug that can also contribute to hyponatremia. Ecstasy use has been linked to hyponatremia due to its effects on the body's fluid balance and electrolyte levels. In an educational context, understanding the potential causes of hyponatremia is crucial for healthcare professionals, especially those involved in medication management. Knowledge of which drugs can lead to hyponatremia allows for better monitoring of patients and prompt intervention if signs of electrolyte imbalance develop. This question serves to reinforce the importance of medication awareness and its potential impact on a patient's overall health and well-being.
Question 3 of 5
Which is not true of hypomagnasemia?
Correct Answer: B
Rationale: In the context of hypomagnesemia, it is crucial to understand the implications of low magnesium levels on physiological processes. The correct answer, B) it causes pre-eclampsia, is the right choice because hypomagnesemia is not a direct cause of pre-eclampsia. Pre-eclampsia is a disorder characterized by high blood pressure and often protein in the urine during pregnancy, and while magnesium sulfate is used in the treatment of eclampsia (seizures in pregnancy), hypomagnesemia itself does not cause pre-eclampsia. Now, let's analyze why the other options are incorrect: A) it increases SA node automaticity: Hypomagnesemia actually decreases SA node automaticity, leading to cardiac arrhythmias. C) it prolongs the QT increasing the risk of Torsades: This is true, as hypomagnesemia can prolong the QT interval and increase the risk of Torsades de Pointes, a specific type of life-threatening ventricular tachycardia. D) it is associated with a 2-3 times increased risk of AF and SVT post AMI: This statement is accurate, as hypomagnesemia is indeed associated with an increased risk of atrial fibrillation (AF) and supraventricular tachycardia (SVT) following an acute myocardial infarction (AMI). Educationally, understanding the effects of electrolyte imbalances like hypomagnesemia is vital for healthcare professionals, especially those working in cardiology, obstetrics, and internal medicine. Recognizing the manifestations and consequences of hypomagnesemia can guide appropriate interventions and improve patient outcomes.
Question 4 of 5
Which agent below does not cause an increased anion gap metabolic acidosis?
Correct Answer: A
Rationale: In the context of nutrition and fluid balance, understanding the causes of metabolic acidosis is crucial for healthcare professionals. Acetazolamide, the correct answer (A), is a carbonic anhydrase inhibitor that causes bicarbonate loss in the urine, leading to a normal anion gap metabolic acidosis. This mechanism is well-documented in pharmacology and physiology literature. Paraldehyde (B) is known to cause an increased anion gap metabolic acidosis due to the production of organic acids. Iron toxicity (C) can lead to metabolic acidosis through various mechanisms such as oxidative stress and mitochondrial dysfunction. Aspirin (D) ingestion can result in an increased anion gap metabolic acidosis due to its effects on cellular metabolism and uncoupling of oxidative phosphorylation. Educationally, this question reinforces the importance of understanding the specific mechanisms by which different agents can disrupt acid-base balance in the body. By identifying the correct answer as acetazolamide and explaining why the other options are incorrect, learners can deepen their knowledge of metabolic acidosis etiology and management. This knowledge is essential for healthcare professionals in diagnosing and treating patients with acid-base disorders.
Question 5 of 5
Which would you give to reverse streptokinase?
Correct Answer: A
Rationale: The correct answer is A) cryoprecipitate. Streptokinase is a thrombolytic agent that works by activating plasminogen, leading to the breakdown of fibrin and ultimately dissolving blood clots. To reverse the effects of streptokinase, fibrinogen replacement is required. Cryoprecipitate is a blood product rich in fibrinogen, making it the appropriate choice for reversing the fibrinolytic effects of streptokinase. Option B) platelets, would not be effective in reversing streptokinase as platelets are not directly involved in the fibrinolytic pathway affected by streptokinase. Option C) factor VIII concentrate is used to treat hemophilia A, a deficiency in factor VIII, and is not relevant to reversing streptokinase. Option D) DDAVP (desmopressin) is a synthetic analog of vasopressin and is used to treat conditions like diabetes insipidus and von Willebrand disease, but it is not indicated for reversing the effects of streptokinase. In an educational context, understanding the mechanism of action of different medications and their specific antidotes or reversal agents is crucial for healthcare professionals, especially those involved in emergency medicine, critical care, or hematology. This knowledge ensures appropriate and timely interventions to manage complications or adverse effects of medications, ultimately improving patient outcomes.